More Alterity Therapeutics Ltd. news
Alterity Therapeutics Ltd.ASX: ATH

Approval of PBT2 Orphan Designation for Huntingtons Disease

Feb 10, 2016 at 8:19 PM EST · Issued by Alterity Therapeutics Ltd.

Filed with ASX · Feb 10, 2016 at 8:19 PM EST · 2 pages · English

On 6ix: 6ix.com/news/approval-of-pbt2-orphan-designation-for-huntingtons-disease

Alterity Therapeutics Ltd. on 6ix

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer